Axial Biotherapeutics Obtains $19,000,000 Series A Funding

  • Feed Type
  • Date
    12/1/2016
  • Company Name
    Axial Biotherapeutics
  • Mailing Address
    800 Boylston St. 15th Floor Boston, MA 02199 USA
  • Company Description
    Axial Biotherapeutics is a biopharmaceutical company harnessing the link between the human gut microbiome and Central Nervous System to develop a new class of therapeutics to improve the quality of life for people with CNS diseases and disorders.
  • Website
    http://www.axialbiotherapeutics.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $19,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Longwood Fund
  • Venture Investor
    Domain Associates
  • Venture Investor
    Heritage Capital

Trending on Xconomy